Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New Trials – Medical Daily
Medical Daily |
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New Trials
Medical Daily Treatment is limited, but new clinical trials of the FDA-approved immunotherapy medication pembrolizumab suggest the drug may offer patients new hope. The drug trials were set up by NYU Langone Medical Center/New York University School of Medicine, … |
